Raymond Siatkowski to Cost-Benefit Analysis
This is a "connection" page, showing publications Raymond Siatkowski has written about Cost-Benefit Analysis.
Connection Strength
0.082
-
VEP testing and visual pathway gliomas: not quite ready for prime time. J AAPOS. 2006 Aug; 10(4):293-5.
Score: 0.066
-
Retinopathy of prematurity in infants with birth weight>or=1250 grams-incidence, severity, and screening guideline cost-analysis. J AAPOS. 2006 Apr; 10(2):128-34.
Score: 0.016